Patient Registry Software Market By Registry (Disease Registries, Health Service Registries, and Product Registries), By Software (Stand-alone Software and Integrated Software), By End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other), Global Analysis to 2023

Patient Registry Software Market Valuation – 2024-2031

According to the new report titled " Patient Registry Software Market By Registry (Disease Registries, Health Service Registries, and Product Registries), By Software (Stand-alone Software and Integrated Software), By End User (Hospitals, Government Organizations and Third Party Administrators (TPAs), and Pharmaceutical, Biotechnology, and Medical Device Companies, and Other), Global Analysis to 2023"

The valuation of the Patient Registry Software market was $1.53 Billion in 2023 and is projected to reach $5.09 Billion by 2032, at a CAGR of 12.47% from 2021 to 2032.

The Patient Registry Software Market was valued at $1.53 Billion by 2023 and expected to grow at CAGR of 12.47% over forecast period.  Patient registry software is a type of healthcare information technology solution designed to collect, store, manage, and analyze data related to patients with specific medical conditions, diseases, or demographic characteristics. These registries serve as valuable tools for healthcare organizations, researchers, and policymakers to track patient outcomes, monitor disease trends, evaluate treatment effectiveness, and support clinical research efforts. Patient registry software enables healthcare organizations and research institutions to collect and analyze large volumes of patient data to identify trends, evaluate treatment outcomes, and generate real-world evidence. As the importance of evidence-based medicine continues to rise, there is a growing demand for robust patient registry solutions to support clinical research and post-market surveillance studies. Chronic diseases such as diabetes, cardiovascular disease, cancer, and respiratory conditions pose significant challenges to healthcare systems worldwide. Patient registry software plays a critical role in managing chronic diseases by tracking patient demographics, disease progression, treatment adherence, and health outcomes over time. Healthcare providers use registry data to implement personalized care plans, monitor disease trends, and improve population health management strategies.

Disease Registries held the largest share in the Patient Registry Software market

By Registry (Disease Registries, Health Service Registries, and Product Registries) where Flavored Drinks plays a crucial role in the Patient Registry Software market. Disease registries are centralized databases or repositories that systematically collect, store, and manage information about individuals diagnosed with specific diseases or medical conditions. These registries serve various purposes, including epidemiological research, clinical studies, quality improvement initiatives, and public health surveillance efforts. Disease registries are valuable tools for conducting observational studies, clinical trials, and comparative effectiveness research. Researchers use registry data to investigate disease etiology, risk factors, treatment outcomes, and long-term prognosis. As the importance of evidence-based medicine continues to rise, there is a growing demand for robust disease registries to support clinical research and inform clinical decision-making. Healthcare organizations use disease registries to monitor and improve the quality of care by tracking clinical outcomes, adherence to clinical guidelines, and healthcare performance metrics. Registries provide data-driven insights to identify variations in care, implement best practices, and optimize treatment strategies, ultimately improving patient safety and health outcomes.

North America headed the Patient Registry Software market in 2023

North America is a hub for clinical research and evidence-based medicine, with a strong emphasis on collecting and analyzing patient data to inform healthcare decision-making. Patient registry software facilitates the creation and management of disease-specific registries, supporting observational studies, clinical trials, and comparative effectiveness research across various medical specialties. Chronic diseases such as diabetes, cardiovascular disease, cancer, and respiratory conditions are major contributors to morbidity and mortality in North America. Patient registry software plays a crucial role in managing chronic diseases by tracking patient demographics, disease progression, treatment adherence, and health outcomes over time. Healthcare providers use registry data to implement personalized care plans, monitor disease trends, and improve population health management strategies. Patient registry software facilitates public health surveillance efforts by tracking disease prevalence, incidence, and trends over time. Registries help public health authorities monitor disease outbreaks, assess the impact of preventive interventions, and allocate resources effectively to address emerging health threats, such as infectious diseases, chronic diseases, and environmental exposures.

Key market players operating in the market that are profiled in the report are

 IBM Corporation (US), Cerner Corporation (US), McKesson Corporation (US), IQVIA Holdings Inc. (US), Optum, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Epic Systems Corporation (US) etc.

Report Scope

Keyplayer

• IQVIA
• IBM Watson Health
• Cerner Corporation
• Epic Systems Corporation
• Phytel
• OpenText
• Global Vision Technologies
• Dacima Software
• Inc.
• Velos
• Inc.
• Syapse
• Premier
• Inc.
• Medstreaming
• FIGmd
• ArborMetrix
• Optum
• Inc.
• Arbor Research Collaborative for Health
• Health Catalyst
• Conduent
• Inc.
• ArborMetrix
• VersaForm Systems Corporation 

Patient Registry Software Market, By Category

Product

• Disease Registry
• Health Service Registry
• Product Registry

Deployment Model

• On-premise
• Web/Cloud-based

Software Type

• Standalone
• Integrated

Functionality

• Population Health Management
• Health Information Exchange
• Patient Care Management
• Point-Of-Care
• Medical Research & Clinical Studies
• Product Outcome Evaluation

End-User

• Government & Tthird party
• Hospitals & Mmedical Ppractices
• Private Ppayers
• Pharma & Mmedical Ddevice Ccompanies
• Research Oorganization
• Banking, Financial Services, and Insurance (BFSI)
• Retail and E-Commerce

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support